Zobrazeno 1 - 10
of 47
pro vyhledávání: '"HL Gelhorn"'
Autor:
KM Fox, A. Booth, ZL Balantac, K Cutts, E. Merinopoulou, C Ambrose, A Cox, M Ross, HL Gelhorn
Publikováno v:
Value in Health. 21:S236
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3345d37f52853be5998bf58c1176a068
https://doi.org/10.1016/j.jval.2018.04.1619
https://doi.org/10.1016/j.jval.2018.04.1619
Publikováno v:
Value in Health. 19:A900
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78e8be9bb24c3f7026d1279da5ba3a14
https://doi.org/10.1016/j.jval.2016.08.201
https://doi.org/10.1016/j.jval.2016.08.201
Autor:
Ross MM; Evidera Inc., Wilmington, NC, USA., Chung Y; AstraZeneca, Wilmington, DE, USA., Carr T; Asthma and Airways Disease Research Center, University of AZ, Tucson, AZ, USA., Ambrose CS; AstraZeneca, Wilmington, DE, USA., Lindsley AW; Amgen, Thousand Oaks, CA, USA., Collacott H; Evidera Inc., Wilmington, NC, USA., Schulz A; Evidera Inc., Wilmington, NC, USA., Desai P; Novartis, East Hanover, NJ, USA., Rane P; Amgen, Thousand Oaks, CA, USA., Williams M; Northern VA Pulmonary and Critical Care Associates PC, Annadale, VA, USA., Gelhorn HL; Evidera Inc., Wilmington, NC, USA.
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Dec; Vol. 61 (12), pp. 1746-1758. Date of Electronic Publication: 2024 Aug 01.
Autor:
Gelhorn HL; Evidera, Bethesda, MD, United States., Ghafoori P; GSK, Collegeville, PA, United States., Cutts K; Evidera, Bethesda, MD, United States., Birch H; GSK, Brentford, United Kingdom., Savva Y; Evidera, Bethesda, MD, United States., Satram S; Vir Biotechnology, Inc., San Francisco, CA, United States., Lloyd E; GSK, Brentford, United Kingdom., Chen WH; GSK, Collegeville, PA, United States.
Publikováno v:
Frontiers in public health [Front Public Health] 2024 May 09; Vol. 12, pp. 1278106. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).
Autor:
Gelhorn HL; Evidera, Bethesda, MD, USA. heather.gelhorn@evidera.com.; Evidera, 7101 Wisconsin Blvd., Suite 1400, Bethesda, MD, 20814, USA. heather.gelhorn@evidera.com., Maher S; Evidera, Bethesda, MD, USA., Sapin H; Eli Lilly and Company, Indianapolis, IN, USA., Poon JL; Eli Lilly and Company, Indianapolis, IN, USA., Boye K; Eli Lilly and Company, Indianapolis, IN, USA.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Dec; Vol. 32 (12), pp. 3359-3371. Date of Electronic Publication: 2023 Jul 25.
Autor:
Thomas C; Patient-Centered Research, Evidera, London, United Kingdom., Ailawadhi S; Divisions of Hematology-Oncology and Cancer Biology, Mayo Clinic, Jacksonville, FL, United States., Popat R; University College London Hospitals NHS Foundation Trust, London, United Kingdom., Kleinman D; Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States., Ross MM; Patient-Centered Research, Evidera, Bethesda, MD, United States., Gorsh B; GSK, Upper Providence, PA, United States., Mulnick S; Patient-Centered Research, Evidera, Bethesda, MD, United States., O'Neill A; GSK, Philadelphia, PA, United States., Paka P; GSK, Philadelphia, PA, United States., Hanna M; GSK, Upper Providence, PA, United States., Krucien N; Patient-Centered Research, Evidera, London, United Kingdom., Molinari A; GSK, Upper Providence, PA, United States.; Rutgers Center for Health Outcomes, Policy, and Economics, Rutgers, The State University of New Jersey, Piscataway, NJ, United States., Gelhorn HL; Patient-Centered Research, Evidera, Bethesda, MD, United States., Perera S; GSK, London, United Kingdom.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2023 Nov 23; Vol. 10, pp. 1271657. Date of Electronic Publication: 2023 Nov 23 (Print Publication: 2023).
Autor:
Mitchell BD; Eli Lilly and Company, Indianapolis, IN, USA., Rentz AM; Evidera, Bethesda, MD, USA., Kummer S; Evidera, Bethesda, MD, USA., Yan Y; Eli Lilly and Company, Indianapolis, IN, USA., Heidenreich S; Evidera, London, UK., Krucien N; Evidera, London, UK., Artime E; Eli Lilly and Company, Indianapolis, IN, USA., Osumili B; Eli Lilly and Company, Indianapolis, IN, USA., Rubio M; Eli Lilly and Company, Indianapolis, IN, USA., Gelhorn HL; Evidera, Bethesda, MD, USA.
Publikováno v:
Journal of diabetes science and technology [J Diabetes Sci Technol] 2023 Nov; Vol. 17 (6), pp. 1623-1633. Date of Electronic Publication: 2022 May 09.
Autor:
Keeley TJH; GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK. tom.x.keeley@gsk.com., Satram S; Vir Biotechnology, San Francisco, CA, USA., Ghafoori P; GlaxoSmithKline, Collegeville, PA, USA., Reyes C; Vir Biotechnology, San Francisco, CA, USA., Birch HJ; GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK., Raymond K; QualityMetric Incorporated, LLC, Johnston, RI, USA., Gelhorn HL; Evidera, Bethesda, MD, USA., Kosinski M; QualityMetric Incorporated, LLC, Johnston, RI, USA., Saucier CD; QualityMetric Incorporated, LLC, Johnston, RI, USA., Mitchell Foster A; QualityMetric Incorporated, LLC, Johnston, RI, USA., Lopuski A; GlaxoSmithKline, Collegeville, PA, USA., Powers JH 3rd; George Washington University School of Medicine, Washington, DC, USA.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Jun; Vol. 32 (6), pp. 1645-1657. Date of Electronic Publication: 2023 Jan 27.
Autor:
Paczkowski R; Eli Lilly and Company, Indianapolis, IN, USA., Poon JL; Eli Lilly and Company, Indianapolis, IN, USA., Cutts KN; Evidera, Patient-Centered Research, 7101 Wisconsin Ave, Suite 1400, Bethesda, MD, 20814, USA., Krucien N; Evidera, Patient-Centered Research, 7101 Wisconsin Ave, Suite 1400, Bethesda, MD, 20814, USA., Osumili B; Eli Lilly and Company Ltd, Bracknell, UK., de Oliveira CP; Eli Lilly and Company, Indianapolis, IN, USA., Hankosky ER; Eli Lilly and Company, Indianapolis, IN, USA., Perez-Nieves M; Eli Lilly and Company, Indianapolis, IN, USA., Radawski C; Eli Lilly and Company, Indianapolis, IN, USA., Gelhorn HL; Evidera, Patient-Centered Research, 7101 Wisconsin Ave, Suite 1400, Bethesda, MD, 20814, USA. healther.gelhorn@evidera.com.
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2023 Jun; Vol. 14 (6), pp. 1057-1072. Date of Electronic Publication: 2023 May 15.
Autor:
Gelhorn HL; Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA., Osumili B; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA., Brown K; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA., Ross MM; Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA., Schulz A; Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA., Fernandez G; Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA., Boye KS; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.
Publikováno v:
Patient preference and adherence [Patient Prefer Adherence] 2023 Mar 22; Vol. 17, pp. 793-805. Date of Electronic Publication: 2023 Mar 22 (Print Publication: 2023).